Table 1.
Demographic and clinical characteristics of study cohorts.
| Characteristics | TOTAL (N = 211) % | ||
|---|---|---|---|
| Age, years | Median (range) | 57 (16–79) | |
| >60 years | 83 | 39.3 | |
| Gender | Male | 120 | 56.9 |
| Female | 91 | 43.1 | |
| Ann Arbor stage | I/II | 120 | 56.9 |
| III/IV | 91 | 43.1 | |
| LDH | Normal | 123 | 58.3 |
| >ULN | 88 | 41.7 | |
| ECOG | 0–1 | 183 | 86.7 |
| 2–4 | 28 | 13.3 | |
| Extranodal sites | 0–1 | 155 | 73.5 |
| ≧2 | 56 | 26.5 | |
| IPI score | Low (0–1) | 109 | 51.7 |
| Intermediate (2–3) | 83 | 39.3 | |
| High (4–5) | 19 | 9.0 | |
Abbreviations: ECOG PS, Eastern Cooperate Oncology Group Performance Status; IPI: International Prognostic Index; LDH, Lactate Dehydrogenase; ULN, Upper Level of Normal